Through an integrated partnership with EVERSANA and CANDEL, we are helping to change patient lives by maximizing the potential of aglatimagene besadenovec to raise the standards of care in oncology while creating long term value for Candel shareholders.

We are excited to execute on the shared vision of how Biotechs innovate and execute as they move from clinical to commercial operation.